Rise Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-272
| Closed | – | – | 1247 |
|
|
2024
Q3 | $0 | Hold |
272
| – | – | ﹤0.01% | 1262 |
|
|
2024
Q2 | $4.11K | Hold |
272
| – | – | ﹤0.01% | 1089 |
|
|
2024
Q1 | $4.01K | Hold |
272
| – | – | ﹤0.01% | 1102 |
|
|
2023
Q4 | $3.64K | Hold |
272
| – | – | ﹤0.01% | 412 |
|
|
2023
Q3 | $3.35K | Hold |
272
| – | – | ﹤0.01% | 411 |
|
|
2023
Q2 | $3.34K | Hold |
272
| – | – | ﹤0.01% | 454 |
|
|
2023
Q1 | $3.34K | Hold |
272
| – | – | ﹤0.01% | 505 |
|
|
2022
Q4 | $3.11K | Hold |
272
| – | – | ﹤0.01% | 506 |
|
|
2022
Q3 | $1K | Hold |
272
| – | – | ﹤0.01% | 696 |
|
|
2022
Q2 | $2K | Hold |
272
| – | – | ﹤0.01% | 599 |
|
|
2022
Q1 | $2K | Hold |
272
| – | – | ﹤0.01% | 575 |
|
|
2021
Q4 | $1.06K | Buy |
+272
| New | +$1.06K | ﹤0.01% | 598 |
|